These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17593814)
21. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317 [TBL] [Abstract][Full Text] [Related]
23. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
24. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Reddel RR; Sutherland RL Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038 [TBL] [Abstract][Full Text] [Related]
25. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200. Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873 [TBL] [Abstract][Full Text] [Related]
26. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867 [TBL] [Abstract][Full Text] [Related]
27. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
28. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1]. Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716 [TBL] [Abstract][Full Text] [Related]
29. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. Jiao JW; Wen F Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580 [TBL] [Abstract][Full Text] [Related]
31. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039 [TBL] [Abstract][Full Text] [Related]
32. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells. Marchetti M; Russo L; Balducci D; Falanga A Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031 [TBL] [Abstract][Full Text] [Related]
33. [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism]. Liu Q; Liu XJ; Chen YJ; Wang J Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):326-30, 357. PubMed ID: 21826992 [TBL] [Abstract][Full Text] [Related]
34. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. López-Marure R; Contreras PG; Dillon JS Eur J Pharmacol; 2011 Jun; 660(2-3):268-74. PubMed ID: 21497598 [TBL] [Abstract][Full Text] [Related]
35. Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells. Pan TL; Hung YC; Wang PW; Chen ST; Hsu TK; Sintupisut N; Cheng CS; Lyu PC Proteomics; 2010 Mar; 10(5):914-29. PubMed ID: 20049856 [TBL] [Abstract][Full Text] [Related]
36. Brassinosteroids cause cell cycle arrest and apoptosis of human breast cancer cells. Steigerová J; Oklešťková J; Levková M; Rárová L; Kolář Z; Strnad M Chem Biol Interact; 2010 Dec; 188(3):487-96. PubMed ID: 20833159 [TBL] [Abstract][Full Text] [Related]
37. Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells. Subramaniam V; Ace O; Prud'homme GJ; Jothy S Exp Mol Pathol; 2011 Feb; 90(1):116-22. PubMed ID: 21040720 [TBL] [Abstract][Full Text] [Related]
38. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models. Yadav B; Taurin S; Larsen L; Rosengren RJ Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638 [TBL] [Abstract][Full Text] [Related]
39. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells. Yadav B; Taurin S; Larsen L; Rosengren RJ Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975 [TBL] [Abstract][Full Text] [Related]
40. Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. Wang J; Wang X; Jiang S; Yuan S; Lin P; Zhang J; Lu Y; Wang Q; Xiong Z; Wu Y; Ren J; Yang H J Neurooncol; 2007 Mar; 82(1):11-21. PubMed ID: 16955220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]